Sofosbuvir and Velpatasvir
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
72626-2701 -
Package NDC
72626-2701-1 -
Application number
NDA208341 -
SPL ID
314b9ef7-c6e5-44c9-9fbf-b0d35a24cd7d -
SPL set ID
d0c1a945-4440-4b5c-81aa-693ed3db597c -
UNII
KCU0C7RS7Z -
UNII
WJ6CA3ZU8B -
RxCUI
1799212
What the source publishes
- Labeler
- Asegua Therapeutics LLC
- Active ingredients
- Velpatasvir and Sofosbuvir
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA AUTHORIZED GENERIC
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Sofosbuvir and Velpatasvir",
"splId": "314b9ef7-c6e5-44c9-9fbf-b0d35a24cd7d",
"labels": [
{
"setId": "d0c1a945-4440-4b5c-81aa-693ed3db597c",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d0c1a945-4440-4b5c-81aa-693ed3db597c",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d0c1a945-4440-4b5c-81aa-693ed3db597c"
}
],
"routes": [
"ORAL"
],
"labeler": "Asegua Therapeutics LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "2 BLISTER PACK in 1 CARTON (72626-2701-1) / 14 TABLET, FILM COATED in 1 BLISTER PACK",
"package_ndc": "72626-2701-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20181114"
}
],
"productId": "72626-2701_314b9ef7-c6e5-44c9-9fbf-b0d35a24cd7d",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "72626-2701",
"deaSchedule": null,
"genericName": "Velpatasvir and Sofosbuvir",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "VELPATASVIR",
"strength": "100 mg/1"
},
{
"name": "SOFOSBUVIR",
"strength": "400 mg/1"
}
],
"applicationNumber": "NDA208341",
"marketingCategory": "NDA AUTHORIZED GENERIC",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20181114",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000191256",
"N0000190113",
"N0000185503",
"N0000190107",
"N0000190108",
"N0000190109",
"N0000191493",
"N0000191258"
],
"unii": [
"KCU0C7RS7Z",
"WJ6CA3ZU8B"
],
"rxcui": [
"1799212"
],
"spl_set_id": [
"d0c1a945-4440-4b5c-81aa-693ed3db597c"
],
"pharm_class_epc": [
"Hepatitis C Virus NS5A Inhibitor [EPC]",
"Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Breast Cancer Resistance Protein Inhibitors [MoA]",
"P-Glycoprotein Inhibitors [MoA]",
"Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
"Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
"Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]",
"RNA Replicase Inhibitors [MoA]"
],
"manufacturer_name": [
"Asegua Therapeutics LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:72626-2701_314b9ef7-c6e5-44c9-9fbf-b0d35a24cd7d"